Leuprolide

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 4054 publications

Efficacy and safety of goserelin vs. leuprolide in premenopausal breast cancer patients receiving adjuvant endocrine therapy: A retrospective cohort study.

Efficacy and safety of goserelin vs. leuprolide in premenopausal breast cancer patients receiving adjuvant endocrine therapy: A retrospective cohort study.

Journal: Medwave

Published: August 19, 2026

Standardized Bone Health Assessment and Treatment Among Prostate Cancer Patients on Androgen Deprivation Therapy in a Large Integrated Managed Care Delivery System.

Standardized Bone Health Assessment and Treatment Among Prostate Cancer Patients on Androgen Deprivation Therapy in a Large Integrated Managed Care Delivery System.

Journal: Journal of pharmacy practice

Published: August 19, 2026

Revisiting the Association of Central Precocious Puberty with Neurovisceral Diseases owing to a Girl with Niemann-Pick Disease Type C.

Revisiting the Association of Central Precocious Puberty with Neurovisceral Diseases owing to a Girl with Niemann-Pick Disease Type C.

Journal: Journal of clinical research in pediatric endocrinology

Published: August 19, 2026

Sustained GnRH Agonism Alters Endocrine Dynamics and Pubertal Progression in Juvenile Rats.

Sustained GnRH Agonism Alters Endocrine Dynamics and Pubertal Progression in Juvenile Rats.

Journal: bioRxiv : the preprint server for biology

Published: July 10, 2026

Treatment of High-Risk Biochemically Recurrent Prostate Cancer with Enzalutamide in Combination with Leuprolide: Secondary End Points from the EMBARK Trial: Erratum.

Treatment of High-Risk Biochemically Recurrent Prostate Cancer with Enzalutamide in Combination with Leuprolide: Secondary End Points from the EMBARK Trial: Erratum.

Journal: The Journal of urology

Published: July 09, 2026

Enzalutamide in biochemically recurrent prostate cancer: clinical implications from EMBARK for real-world practice.

Enzalutamide in biochemically recurrent prostate cancer: clinical implications from EMBARK for real-world practice.

Journal: Future oncology (London, England)

Published: July 09, 2026

Enzalutamide in biochemically recurrent prostate cancer: key findings from subsequent analyses of EMBARK and their implications in clinical practice.

Enzalutamide in biochemically recurrent prostate cancer: key findings from subsequent analyses of EMBARK and their implications in clinical practice.

Journal: Future oncology (London, England)

Published: June 23, 2026

Statin Use Attenuates Leuprolide-Associated Coronary Atherosclerosis Progression: A Secondary Analysis of the REVELUTION Trial.

Statin Use Attenuates Leuprolide-Associated Coronary Atherosclerosis Progression: A Secondary Analysis of the REVELUTION Trial.

Journal: JACC. CardioOncology

Published: May 29, 2026

A phase II study of androgen receptor inhibition by darolutamide in combination with leuprolide acetate and exemestane in recurrent adult-type ovarian granulosa cell tumor.

A phase II study of androgen receptor inhibition by darolutamide in combination with leuprolide acetate and exemestane in recurrent adult-type ovarian granulosa cell tumor.

Journal: Gynecologic oncology

Published: May 08, 2026

Small Cell Transformation of Metachronous ALK + ve Lung and Prostatic Adenocarcinoma following Initial Response to Ceritinib and Androgen Deprivation Therapies and Metastases to Two Different Organs: Guidance through FDG-PET/CT and 68 Ga-PSMA-11 PET-CT and Biopsy-Immunohistochemistry Correlation.

Small Cell Transformation of Metachronous ALK + ve Lung and Prostatic Adenocarcinoma following Initial Response to Ceritinib and Androgen Deprivation Therapies and Metastases to Two Different Organs: Guidance through FDG-PET/CT and 68 Ga-PSMA-11 PET-CT and Biopsy-Immunohistochemistry Correlation.

Journal: World journal of nuclear medicine

Published: May 04, 2026

QIM26-312: A Scalable Model for Oncology Home Leuprolide Injections.

QIM26-312: A Scalable Model for Oncology Home Leuprolide Injections.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: April 29, 2026

BMI-SDS Changes During GnRHa Therapy in 150 Girls with Idiopathic Central Precocious Puberty: Follow-up Through Final Height

BMI-SDS Changes During GnRHa Therapy in 150 Girls with Idiopathic Central Precocious Puberty: Follow-up Through Final Height

Journal: Journal of clinical research in pediatric endocrinology

Published: April 24, 2026

Showing 1-12 of 4,054

Last Updated: 09/26/2026